Speaker Profile
M.D., Ph.D., CMO, Quell Tx
Biography
Luke Devey is a physician-scientist and biopharmaceutical executive whose career spans academic surgery, translational immunology, experimental medicine and senior leadership in global pharma, biotech and venture capital. His work has focuses on translating mechanistic insight into therapeutic development, from early target discovery and biomarker strategy through to early phase clinical studies. Luke served in roles of increasing responsibility at GSK and Celgene prior to leading Translational Sciences at Janssen Immunology, concurrent with a visiting Professorship in immunology at Oxford.
Luke serves currently as Chief Medical Officer at Quell Therapeutics, and Venture Partner at SV Health Investors. Quell is currently executing upon the CHILL Phase 1/2 study of autologous CD19 CAR-Treg therapy in refractory rheumatoid arthritis and systemic sclerosis, with clinical data anticipated in 2027.
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Mark Genovese, Eli Lilly
PMWC Award Ceremony
• Miriam Merad, Mount Sinai (Luminary)
• Jeffrey A. Bluestone, UCSF (Luminary)
Featured Speakers
• Miriam Merad, Mount Sinai
• Jeffrey A. Bluestone, UCSF
• Gallia Levy, Gilead
• Marcela V. Maus, Harvard
• Nick Wilson, Biogen
• Megan Levings, BC Children's Hospital Research Institute
• Min Bao, Kali Therapeutics
• Purvesh Khatri, Stanford
• Heleen Scheerens, Genentech
• Pascal Geldsetzer, Stanford
• Dan Littman, NYU
• Anne Kasmar, Parexel
Macrophages Across Inflammation, Cancer & Aging
Master regulators of tissue health and disease across precision immunology.
Immune Reset in Autoimmune Disease
CAR-T, in vivo CAR, and the pursuit of durable remission.
Beyond Broad Immunosuppression
Tolerance, Tregs, and disease-modifying approaches.
Turning Biomarkers on Their Head
What we can measure before we can reliably predict response.
Precision Immunology in Clinical Development
Trial enrichment, deeper endpoints, response prediction, and regulatory strategy.
The Microbial Roots of Autoimmunity
Chronic infection, dysbiosis, and microbial signals shaping disease.
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
